Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

At the Senate Finance nomination hearing yesterday, he declined to give a yes-or-no answer about Affordable Care Act tax credit rule renewal.

She predicts that restructuring big, vertically integrated health care companies could help the government save money.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...

Sees FY25 adjusted revenue at least $252,000. Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

Supporters say a new bill would protect a federal program from attacks by pharmaceutical companies. That program requires a small portion of money from drug companies to go to safety net providers who ...